Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (SURF301)
NCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06960395 Brief Summary This Phase 1, first-in-human (FIH), dose-escalation and dose-expansion…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardNCT 06539338 Brief Summary The purpose of this first-in-human study is to…
Read more arrow_forwardNCT 06712316 Brief Summary This is a Phase 2/3, multisite, randomized, open-label…
Read more arrow_forwardNCT 05997615 Brief Summary The study will be conducted in 4 parts…
Read more arrow_forwardNCT 06120491 Brief Summary The intention of the study is to demonstrate…
Read more arrow_forwardNCT 05261399 Brief Summary Clinical study to investigate the efficacy and safety…
Read more arrow_forwardNCT 05611931 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forward